Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Spray-Dried mRNA Nanoparticle Powder for Multiple Delivery Methods with 3-Year Stability in the Fridge

Updated

Abstract

Spray-dried mRNA-lipid nanoparticle (mRNA-LNP) dry powder maintains stability for over 3 years under refrigerated conditions.

  • Liquid formulations of mRNA-LNPs show significant degradation within 6-9 months, highlighting their limited stability.
  • Trehalose has been identified as an effective matrix former for creating stable dry powder formulations of mRNA-LNPs.
  • The dry powder platform allows for controlled particle size, low residual moisture, and preservation of lipid properties upon reconstitution.
  • Reconstituted dry powder maintains in vivo protein expression comparable to liquid formulations after intravenous and intramuscular administration.
  • Direct administration of dry powder enables targeted protein expression in the lungs, suggesting alternative delivery methods.
  • The dry powder formulation overcomes the need for ultra-cold storage, potentially improving global accessibility to mRNA therapies.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free